In 17 out of 23 subgroups, MDT could predict OS of mRCC and showed a trend toward longer OS.
← all excerpts
Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients.
1
—
—
In 17 out of 23 subgroups, MDT could predict OS of mRCC and showed a trend toward longer OS.